Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
作者： Lewin T. Wint , George Joseph Quallich
DOI:
关键词:
摘要: The present invention is directed to certain pharmaceutically acceptable salts of the therapeutically potent selective serotonin reuptake inhibitor, sertraline: Formula (I), and pharmaceutical compositions thereof, wherein said are selected from group consisting p-toluenesulfonic acid salt, fumaric benzenesulfonic benzoic L-tartaric salt (-)-camphor-10-sulfonic salt.
lens.org 参考文章(5)
Ilpo Laitinen, Method for preparing sertraline ,(2002)
William John Curatolo, Mary Tanya Am Ende, Hylar Lewis Friedman, James Blair West, Dwayne Thomas Friesen, Scott Max Herbig, Ravi Mysore Shankar, Sertraline salts and sustained-release dosage forms of sertraline ,(1998)
Nancy Jane Harper, Willard Mckowan Welch, Gautam Ramchandra Ranade, Sertraline oral concentrate ,(1999)
Tamar Nidam, Marioara Mendelovici, Eduard Schwartz, Anita Liberman, Judith Aronhime, Sertraline hydrochloride Form II and methods for the preparation thereof ,(2006)
Julius F. Remenar, J. Michael MacPhee, Bridget K. Larson, Viraj A. Tyagi, Jason H. Ho, David A. McIlroy, Magali B. Hickey, Paul B. Shaw, Örn Almarsson, Salt Selection and Simultaneous Polymorphism Assessment via High-Throughput Crystallization: The Case of Sertraline Organic Process Research & Development. ,vol. 7, pp. 990- 996 ,(2003) , 10.1021/OP034115+